Form 4: Jain Acquires Omada Health RSUs

Sachin H. Jain, a Director at Omada Health, Inc., acquired 10,882 restricted stock units on June 16, 2026.

Summary

• Sachin H. Jain, a Director at Omada Health, Inc. (OMDA), acquired 10,882 restricted stock units (RSUs) on June 16, 2026.
• These RSUs are for Omada Health's common stock.
• The acquisition was made at a price of $0 per unit.
• Following this transaction, Mr. Jain beneficially owns 20,618 shares of common stock.
• The RSUs will vest fully on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of stockholders, provided service continues through the vesting date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The acquisition of RSUs by a director is a standard compensation practice and does not inherently signal a significant positive or negative development for the company's stock.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition of RSUs indicates a long-term incentive alignment between management and shareholders.

Negatives

• The acquisition of RSUs at $0 cost is a standard compensation practice and not necessarily a reflection of market value or a discount purchase.

Future Outlook

The RSUs are set to vest on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of stockholders, subject to continued service.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of RSUs by a director, are common in the health tech sector as a means of executive compensation and long-term incentive alignment. The specific details of vesting schedules are crucial for understanding the potential future dilution and management's commitment.

Stakeholder Impact

• Shareholders: Potential for future share dilution upon vesting of RSUs. The acquisition by a director may be interpreted as a sign of confidence, potentially positively influencing sentiment.
• Employees: The vesting schedule for RSUs is a standard component of executive compensation, aligning employee incentives with company performance.
• Management: The RSUs serve as a long-term incentive for the director, encouraging continued service and focus on company growth.

Next Steps

• Vesting of RSUs on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of stockholders.

Key Dates

Keywords

Omada Health, OMDA, Form 4, Insider Trading, Restricted Stock Units, RSU, Director, Beneficial Ownership, Securities Exchange Act